Dare Bioscience, Inc. Interest Expense
Dare Bioscience, Inc. (DARE) reported Interest Expense of $322.63 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-28.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2018-03-28
- Dare Bioscience, Inc. interest expense for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
- Dare Bioscience, Inc. interest expense for the quarter ending 2017-03-31 was $797.00K, a 18.96% increase year-over-year.
- Dare Bioscience, Inc. interest expense for the quarter ending 2016-12-31 was $457.00K, a 33.67% decline year-over-year.
- Dare Bioscience, Inc. interest expense for the quarter ending 2016-09-30 was $521.00K, a 2.36% increase year-over-year.
- Dare Bioscience, Inc. interest expense for fiscal 2017 was $322.63K, a 666.41% increase from fiscal 2016.
- Dare Bioscience, Inc. interest expense for fiscal 2016 was $42.10K, a 98.27% decline from fiscal 2015.
- Dare Bioscience, Inc. interest expense for fiscal 2015 was $2.43M, a 124.56% increase from fiscal 2014.
- Dare Bioscience, Inc. interest expense for fiscal 2014 was $1.08M, a 27.17% decline from fiscal 2013.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed | Interest Expense 100 month |
|---|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | $322.63K 10-K · filed 2018-03-28 | ||||||||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $797.00K 10-Q · filed 2017-08-14 | $1.25M derived: sum of 3 quarters · filed 2017-08-14 | $1.77M derived: sum of 4 quarters · filed 2017-08-14 | |||||
| 2017-03-31 | $797.00K 10-Q · filed 2017-05-12 | $1.25M derived: sum of 2 quarters · filed 2017-06-13 | $1.77M derived: sum of 3 quarters · filed 2017-06-13 | $2.37M derived: sum of 4 quarters · filed 2017-08-14 | |||||
| 2016-12-31 | $457.00K 10-K/A · filed 2017-06-13 | $978.00K derived: sum of 2 quarters · filed 2017-06-13 | $1.57M derived: sum of 3 quarters · filed 2017-08-14 | $42.10K 10-K · filed 2018-03-28 | $2.24M 10-K · filed 2017-03-31 | ||||
| 2016-09-30 | $521.00K 10-K/A · filed 2017-06-13 | $1.12M derived: sum of 2 quarters · filed 2017-08-14 | $1.78M 10-Q · filed 2016-11-03 | $2.48M derived: sum of 4 quarters · filed 2017-08-14 | |||||
| 2016-06-30 | $597.00K 10-Q · filed 2017-08-14 | $1.26M 10-Q · filed 2017-08-14 | $1.96M derived: sum of 3 quarters · filed 2017-08-14 | $2.46M derived: sum of 4 quarters · filed 2017-08-14 | |||||
| 2016-03-31 | $670.00K 10-K/A · filed 2017-06-13 | $663.00K 10-Q · filed 2016-05-02 | $1.36M derived: sum of 2 quarters · filed 2017-06-13 | $1.87M derived: sum of 3 quarters · filed 2017-06-13 | $2.38M derived: sum of 4 quarters · filed 2017-06-13 | ||||
| 2015-12-31 | $689.00K 10-K/A · filed 2017-06-13 | $1.20M derived: sum of 2 quarters · filed 2017-06-13 | $1.71M derived: sum of 3 quarters · filed 2017-06-13 | $2.43M 10-K/A · filed 2017-06-13 | |||||
| 2015-09-30 | $509.00K 10-K/A · filed 2017-06-13 | $1.02M derived: sum of 2 quarters · filed 2017-06-13 | $1.74M 10-Q · filed 2016-11-03 | $1.75M 10-Q · filed 2015-11-16 | $1.91M derived: sum of 4 quarters · filed 2017-06-13 | ||||
| 2015-06-30 | $513.00K 10-K/A · filed 2017-06-13 | $1.23M 10-Q · filed 2016-08-04 | $1.24M 10-Q · filed 2015-08-06 | $1.40M derived: sum of 3 quarters · filed 2017-06-13 | $1.59M derived: sum of 4 quarters · filed 2017-06-13 | ||||
| 2015-03-31 | $721.00K 10-K/A · filed 2017-06-13 | $884.00K derived: sum of 2 quarters · filed 2017-06-13 | $1.07M derived: sum of 3 quarters · filed 2017-06-13 | $1.34M derived: sum of 4 quarters · filed 2017-06-13 | |||||
| 2014-12-31 | $163.00K 10-K · filed 2016-03-10 | $354.00K derived: sum of 2 quarters · filed 2016-03-10 | $622.00K derived: sum of 3 quarters · filed 2016-03-10 | $1.08M 10-K/A · filed 2017-06-13 | |||||
| 2014-09-30 | $191.00K 10-K · filed 2016-03-10 | $459.00K derived: sum of 2 quarters · filed 2016-03-10 | $920.00K 10-Q · filed 2015-11-16 | $1.35M derived: sum of 4 quarters · filed 2016-03-10 | |||||
| 2014-06-30 | $268.00K 10-K · filed 2016-03-10 | $729.00K 10-Q · filed 2015-08-06 | $1.16M derived: sum of 3 quarters · filed 2016-03-10 | $1.54M derived: sum of 4 quarters · filed 2016-03-10 | |||||
| 2014-03-31 | $461.00K 10-K · filed 2016-03-10 | $891.00K derived: sum of 2 quarters · filed 2016-03-10 | $1.27M derived: sum of 3 quarters · filed 2016-03-10 | $1.59M derived: sum of 4 quarters · filed 2016-03-10 | $2.86M 10-Q · filed 2014-05-27 | ||||
| 2013-12-31 | $430.00K 10-K · filed 2015-03-19 | $808.00K derived: sum of 2 quarters · filed 2015-03-19 | $1.13M derived: sum of 3 quarters · filed 2015-03-19 | $1.49M 10-K · filed 2016-03-10 | |||||
| 2013-09-30 | $378.00K 10-K · filed 2015-03-19 | $704.00K derived: sum of 2 quarters · filed 2015-03-19 | $1.06M 10-Q · filed 2014-11-13 | ||||||
| 2013-06-30 | $326.00K 10-K · filed 2015-03-19 | $679.00K 10-Q · filed 2014-08-12 | |||||||
| 2013-03-31 | $353.00K 10-K · filed 2015-03-19 | ||||||||
| 2012-12-31 | $567.00K 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |